AU2898300A - Modulators of fgl2 prothrombinase - Google Patents

Modulators of fgl2 prothrombinase

Info

Publication number
AU2898300A
AU2898300A AU28983/00A AU2898300A AU2898300A AU 2898300 A AU2898300 A AU 2898300A AU 28983/00 A AU28983/00 A AU 28983/00A AU 2898300 A AU2898300 A AU 2898300A AU 2898300 A AU2898300 A AU 2898300A
Authority
AU
Australia
Prior art keywords
modulators
fgl2 prothrombinase
fgl2
prothrombinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28983/00A
Inventor
Gary Levy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2898300A publication Critical patent/AU2898300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU28983/00A 1999-02-26 2000-02-25 Modulators of fgl2 prothrombinase Abandoned AU2898300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12210999P 1999-02-26 1999-02-26
US60122109 1999-02-26
PCT/CA2000/000191 WO2000051636A1 (en) 1999-02-26 2000-02-25 Modulators of fgl2 prothrombinase

Publications (1)

Publication Number Publication Date
AU2898300A true AU2898300A (en) 2000-09-21

Family

ID=22400667

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28983/00A Abandoned AU2898300A (en) 1999-02-26 2000-02-25 Modulators of fgl2 prothrombinase

Country Status (3)

Country Link
AU (1) AU2898300A (en)
CA (1) CA2362566A1 (en)
WO (1) WO2000051636A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003066848A1 (en) * 2002-02-07 2003-08-14 Trillium Therapeutics Inc. Porcine fgl2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06505152A (en) * 1990-12-21 1994-06-16 ザ ロックフェラー ユニヴァーシティ Liver-accumulating transcription factors

Also Published As

Publication number Publication date
WO2000051636A1 (en) 2000-09-08
CA2362566A1 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
AU5259100A (en) Medicament
AU3692700A (en) High speed electro-optic modulator
AU1173201A (en) Skin-gripper
AU2001271434A1 (en) Novel skateboard-bicycle combination
AU2919001A (en) Syringe
AU4318000A (en) Agarobiose-containing composition
AU2678800A (en) Modified calycins
AU4340900A (en) Devices
AU1887401A (en) Medicinal composition
AU1290501A (en) Composition
AU6062700A (en) Devices
AU5547000A (en) Novel treatment
AU2023701A (en) Sketcher
AU1533601A (en) Hollow-needle devices
AU1541601A (en) Syringes
AU4556800A (en) Novel treatment
AU4568900A (en) Improved can
AU2359301A (en) Novel ss-defensins
AU6310600A (en) Composition
AU7711800A (en) Novel uses of 2-bromopalmitate
AU1901801A (en) Glucofuranoses
AU2898300A (en) Modulators of fgl2 prothrombinase
AU6062600A (en) Devices
AU3133400A (en) Syringe
AU6711500A (en) Dressing

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase